Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Women are more likely to have long-term post-COVID symptoms than men.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Cannabinoids may help treat various skin conditions.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

Stress may trigger hair loss by affecting immune protection in hair follicles.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Some drugs may help treat both COVID-19 and radiation injury.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Generic drug inserts in Saudi Arabia often have inaccurate information, needing better regulation and quality control.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.